NexgenRx Stock Price, News & Analysis (CVE:NXG)

C$0.24 0.00 (0.00 %)
(As of 12/12/2017 10:59 AM ET)
Previous CloseC$0.24
Today's RangeC$0.24 - C$0.24
52-Week RangeC$0.20 - C$0.35
Volume38,000 shs
Average Volume50,468 shs
Market CapitalizationC$14.42 million
P/E RatioN/A
Dividend YieldN/A
Beta0.3

About NexgenRx (CVE:NXG)

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans in Canada. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company also provides individual and aggregate stop loss products; medical emergency and travel assistance insurance services; administrative services, including the collection and payment of premiums for life and LTD coverage; Web claims submission services; a suite of reporting tools; and direct deposit services. NexgenRx Inc. offers its benefits to plan sponsors, brokers, consultants, and third party administrators. The company was founded in 2003 and is headquartered in Toronto, Canada.

Receive NXG News and Ratings via Email

Sign-up to receive the latest news and ratings for NXG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Health Care Plans
Sub-IndustryN/A
SectorHealthcare
SymbolCVE:NXG
CUSIPN/A
Phone+1-416-6953393

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net Margins-7.62%
Return on Equity-56.53%
Return on Assets-5.02%

Miscellaneous

EmployeesN/A
Outstanding Shares60,392,000

NexgenRx (CVE:NXG) Frequently Asked Questions

What is NexgenRx's stock symbol?

NexgenRx trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NXG."

When will NexgenRx make its next earnings announcement?

NexgenRx is scheduled to release their next quarterly earnings announcement on Friday, March, 30th 2018. View Earnings Estimates for NexgenRx.

Who are some of NexgenRx's key competitors?

Who are NexgenRx's key executives?

NexgenRx's management team includes the folowing people:

  • Thomas F. Corcoran, Chairman of the Board
  • Ronald C. Loucks, President, Chief Executive Officer, Director
  • Kelly Ehler CPA, Interim Chief Financial Officer
  • Patrick G. Crowley, Director
  • Barry J. Reiter, Director (Age 66)
  • Ralph Soberano, Director
  • David A. Rosenkrantz, Independent Director

How do I buy NexgenRx stock?

Shares of NexgenRx and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is NexgenRx's stock price today?

One share of NexgenRx stock can currently be purchased for approximately C$0.24.

How big of a company is NexgenRx?

NexgenRx has a market capitalization of C$14.42 million.

How can I contact NexgenRx?

NexgenRx's mailing address is 185 the West Mall Suite 600, ETOBICOKE, ON M9C 5L5, Canada. The company can be reached via phone at +1-416-6953393.


MarketBeat Community Rating for NexgenRx (NXG)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  15 (Vote Outperform)
Underperform Votes:  18 (Vote Underperform)
Total Votes:  33
MarketBeat's community ratings are surveys of what our community members think about NexgenRx and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

NexgenRx (CVE:NXG) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for NexgenRx (CVE:NXG)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

NexgenRx (CVE:NXG) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for NexgenRx (CVE:NXG)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

NexgenRx (CVE NXG) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for NexgenRx (CVE:NXG)

NexgenRx (CVE NXG) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/11/2017Paul Everett CrossettInsiderBuy20,000C$0.24C$4,800.00
12/5/2017Paul Everett CrossettInsiderBuy20,000C$0.24C$4,800.00
11/22/2017Paul Everett CrossettInsiderBuy20,000C$0.23C$4,600.00
11/20/2017Paul Everett CrossettInsiderBuy14,500C$0.23C$3,335.00
10/31/2017Paul Everett CrossettInsiderBuy16,000C$0.23C$3,680.00
10/27/2017Paul Everett CrossettInsiderBuy500C$0.21C$105.00
10/20/2017Paul Everett CrossettInsiderBuy20,000C$0.22C$4,400.00
10/6/2017Paul Everett CrossettInsiderBuy58,000C$0.22C$12,760.00
10/4/2017Paul Everett CrossettInsiderBuy1,500C$0.23C$345.00
9/26/2017Paul Everett CrossettInsiderBuy500C$0.23C$115.00
8/17/2017Paul Everett CrossettInsiderBuy500C$0.23C$115.00
8/9/2017Paul Everett CrossettInsiderBuy12,000C$0.23C$2,760.00
8/8/2017Paul Everett CrossettInsiderBuy14,500C$0.23C$3,335.00
8/4/2017Paul Everett CrossettInsiderBuy31,000C$0.24C$7,440.00
7/31/2017Paul Everett CrossettInsiderBuy45,500C$0.23C$10,465.00
7/18/2017Paul Everett CrossettInsiderBuy25,000C$0.24C$6,000.00
7/4/2017Paul Everett CrossettInsiderBuy40,000C$0.24C$9,600.00
6/28/2017Paul Everett CrossettInsiderBuy45,000C$0.24C$10,800.00
6/27/2017Paul Everett CrossettInsiderBuy40,000C$0.24C$9,600.00
6/20/2017Paul Everett CrossettInsiderBuy30,000C$0.24C$7,200.00
6/14/2017Paul Everett CrossettInsiderBuy25,000C$0.24C$6,000.00
6/8/2017Paul Everett CrossettInsiderBuy50,000C$0.24C$12,000.00
6/7/2017Paul Everett CrossettInsiderBuy25,000C$0.24C$6,000.00
6/6/2017Paul Everett CrossettInsiderBuy50,000C$0.24C$12,000.00
6/5/2017Paul Everett CrossettInsiderBuy108,000C$0.24C$25,920.00
4/5/2017Paul Everett CrossettInsiderBuy78,000C$0.24C$18,720.00
3/20/2017Paul Everett CrossettInsiderBuy500C$0.24C$120.00
3/15/2017Paul Everett CrossettInsiderBuy27,000C$0.25C$6,750.00
3/14/2017Paul Everett CrossettInsiderBuy101,000C$0.25C$25,250.00
2/28/2017Paul Everett CrossettInsiderBuy10,000C$0.25C$2,500.00
2/21/2017Paul Everett CrossettInsiderBuy23,000C$0.25C$5,750.00
2/16/2017Paul Everett CrossettInsiderBuy14,500C$0.24C$3,480.00
2/10/2017Paul Everett CrossettInsiderBuy110,500C$0.24C$26,520.00
2/9/2017Paul Everett CrossettInsiderBuy15,000C$0.26C$3,900.00
2/3/2017Paul Everett CrossettInsiderBuy16,500C$0.25C$4,125.00
2/1/2017Paul Everett CrossettInsiderBuy22,500C$0.25C$5,625.00
1/30/2017Paul Everett CrossettInsiderBuy500C$0.23C$115.00
1/27/2017Paul Everett CrossettInsiderBuy20,000C$0.23C$4,600.00
1/24/2017Paul Everett CrossettInsiderBuy20,000C$0.23C$4,600.00
1/23/2017Paul Everett CrossettInsiderBuy5,000C$0.23C$1,150.00
5/6/2016Paul Everett CrossettInsiderBuy61,000C$155.00C$9,455,000.00
3/15/2016Paul Everett CrossettInsiderBuy5,000C$0.16C$775.00
3/14/2016Paul Everett CrossettInsiderBuy50,000C$0.16C$7,750.00
3/10/2016Paul Everett CrossettInsiderBuy21,000C$0.15C$3,150.00
3/4/2016Paul Everett CrossettInsiderBuy75,000C$0.16C$11,625.00
3/2/2016Paul Everett CrossettInsiderBuy25,000C$0.16C$3,875.00
2/26/2016Paul Everett CrossettInsiderBuy23,000C$0.16C$3,565.00
2/25/2016Paul Everett CrossettInsiderBuy25,000C$0.16C$3,875.00
2/2/2016Paul Everett CrossettInsiderBuy25,000C$0.15C$3,750.00
1/26/2016Paul Everett CrossettInsiderBuy25,000C$0.16C$4,000.00
12/2/2015Paul Everett CrossettInsiderBuy5,000C$0.15C$750.00
11/30/2015Paul Everett CrossettInsiderBuy25,000C$0.17C$4,250.00
9/23/2015Ronald Campbell LoucksDirectorBuy100,000C$0.15C$15,000.00
6/30/2015Ronald Campbell LoucksDirectorBuy600,000C$0.17C$102,000.00
(Data available from 1/1/2013 forward)

Headlines

NexgenRx (CVE NXG) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

NexgenRx (CVE:NXG) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

NexgenRx (CVE NXG) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.